已收盘 09-06 16:00:00 美东时间
+0.010
+0.72%
Ladenburg Thalmann analyst Michael Higgins downgrades Marinus Pharma (NASDAQ:MRNS) from Buy to Neutral.
08-14 19:48
H.C. Wainwright analyst Douglas Tsao has reiterated their bullish stance on MRN...
08-14 18:18
Marinus Pharmaceuticals Shares Fall 4% After Missing Q2 Revenue Estimates
08-13 21:34
Marinus Pharmaceuticals Inc - Full Year 2024 Guidance Remains Unchanged
08-13 19:05
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 202...
08-13 19:01
Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 20...
07-30 20:00
A class action lawsuit was filed against Marinus Pharmaceuticals, Inc. ($MRNS) ...
07-22 15:23
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
07-08 07:00
Truist Securities analyst Joon Lee maintains Marinus Pharma (NASDAQ:MRNS) with a Buy and maintains $10 price target.
06-19 01:49
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
06-18 18:20